GILD daily
GILD monthly
Summary
Suffice to add... GILD is my favourite health/bio stock.
--
Based on latest earnings and a stock price in AH of the $75s, forward price earnings multiple: 8/7s, with a yield of around 2.8%. On any basis, that is a ludicrously low valuation.
Seen on a giant multi-year chart, price structure across the last few months is a bull flag. It will be provisionally confirmed with a break >85.73. Basic target is the $90 threshold, and then $110, which seems viable by mid 2018.
To be clear, I am s/t bearish the stock, but m/t hyper bullish.
